Trauma Under Psychedelics: MDMA Shows Protective Effects During the Peritraumatic Period
In a naturalistic cohort of 772 survivors of the October 7 Supernova festival attack, participants who were under the influence of MDMA during the trauma reported lower psychological distress, fewer PTSD symptoms, greater social interaction and better sleep in the one to four months post-attack compared with those who were sober, whereas cannabis and/or alcohol use was associated with worse outcomes. These novel findings suggest a putative protective role for MDMA during the peritraumatic period and warrant mechanistic and longitudinal investigation.
Abstract
Traumatic events play a causal role in the etiology of stress-related psychopathologies such as depression and posttraumatic stress disorder (PTSD). Recent research highlighted the therapeutic potential of psychoactive substances in alleviating trauma symptoms among chronic stress-related patients. This study is the first to investigate the impact of psychoactive substances consumed during actual trauma exposure. Our cohort includes 772 adult survivors (487 males, Mean±SD Age: 26.96±6.55) of the high-casualty attack that occurred at the Supernova festival in Israel on October 7th, 2023. Survivors completed the study during the peritraumatic period of one to four months following the attack. Primary outcomes include the PTSD Checklist for DSM-5 (PCL-5), the Kessler Psychological Distress Scale (K6), and a self-reported rating of feeling overwhelmed. Secondary outcomes include subjective experiences during the attack and reports on social interactions and sleep quality. All survivors reported being in direct danger of death during the attack. Approximately two-thirds of the sampled survivors were under the influence of psychoactive substances at the time of the attack, including LSD, MDMA, Ketamine, Cannabis, and Alcohol, creating a tragic and unique natural experiment to study the impact of psychoactive compounds on trauma processing. Analysis revealed that participants that were under the influence of MDMA during the attack (n=99) reported feeling less overwhelmed, having more social interactions, improved sleep quality, and reduced psychological distress compared to those not under the influence of any substance during the attack (n=216). In contrast, those consuming Cannabis and/or Alcohol during the attack (n=68) showed higher psychological distress, more PTSD symptoms, and worse sleep quality compared to those not under the influence of any substance during the attack. Together, these novel findings suggest that trauma exposure under the influence of MDMA is associated with reduced psychological distress and higher sociality, possibly mediated through MDMA’s known effects of reducing negative emotions and elevating prosociality, while Cannabis and/or Alcohol consumption produces deleterious effects. Further research is needed to explore the cognitive and physiological mechanisms linking psychoactive substances to trauma recovery and establish the putative protective role of MDMA.
Research Summary of 'Trauma Under Psychedelics: MDMA Shows Protective Effects During the Peritraumatic Period'
Introduction
Netzer and colleagues frame the study within the well‑established observation that exposure to traumatic events (TEs) can precipitate disorders such as PTSD and depression, and that individuals vary markedly in their acute physiological, cognitive and emotional responses to trauma. Recent work has highlighted the therapeutic promise of psychoactive compounds, particularly MDMA‑assisted psychotherapy for chronic PTSD; however, almost nothing is known about outcomes when severe trauma is experienced while a person is acutely under the influence of psychoactive substances. The investigators capitalised on a tragic natural experiment: the October 7th 2023 terror attack at the Supernova music festival in Israel, where many attendees were under the influence of psychoactive drugs when the mass trauma unfolded. The study set out to examine how substance use at the time of the attack related to subjective experiences during the TE, peritraumatic processing in the following weeks, and early clinical state (mental distress and PTSD symptom severity) assessed four to twelve weeks post‑event. The focus was especially on MDMA because of its known prosocial and fear‑reducing properties and its therapeutic relevance for PTSD.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topics
- APA Citation
Netzer, O., Magal, N., Stern, Y., Polinsky, T., Gross, R., Admon, R., & Salomon, R. (2024). Trauma Under Psychedelics: MDMA Shows Protective Effects During the Peritraumatic Period. https://doi.org/10.1101/2024.03.28.587237
References (8)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Krediet, E., Bostoen, T., Breeksema, J. J. et al. · International Journal of Neuropsychopharmacology (2020)
Mitchell, J., Ot’alora G, M., van der Kolk, B. et al. · Nature Medicine (2023)
Bershad, A. K., Miller, M. A., Baggot, M. J. et al. · Journal of Psychopharmacology (2016)
Jerome, L., Feduccia, A. A., Wang, J. B. et al. · Psychopharmacology (2020)
Mithoefer, A. T., Mithoefer, M. C., Feduccia, A. A. et al. · Lancet Psychiatry (2018)
Mithoefer, M. C., Feduccia, A. A., Jerome, L. et al. · Psychopharmacology (2019)
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
Cited By (3)
Papers in Blossom that reference this study
Evens, R., Uyar, A., Gosslau, E. et al. · Psychological Medicine (2026)
Karp Barnir, E., Rubinstein, Z., Abend, R. et al. · Journal of Psychopharmacology (2025)
Ertl, N., Ashraf, I., Azizi, L. et al. · Biorxiv (2025)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.